These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 2367062)

  • 1. Effectiveness of tiazofurin (NSC 286193) in treating disseminated tumor cells and micrometastases in mice.
    Lapis K; Pápay J; Paku S
    Oncology; 1990; 47(4):359-64. PubMed ID: 2367062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin.
    Finlay GJ; Ching LM; Wilson WR; Baguley BC
    J Natl Cancer Inst; 1987 Aug; 79(2):291-6. PubMed ID: 3474463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships between the cytotoxicity of tiazofurin and its metabolism by cultured human lung cancer cells.
    Carney DN; Ahluwalia GS; Jayaram HN; Cooney DA; Johns DG
    J Clin Invest; 1985 Jan; 75(1):175-82. PubMed ID: 2856924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II study of tiazofurin (NSC 286193) in the treatment of advanced small cell bronchogenic carcinoma.
    Holoye PY; Carr DT; Dhingra HM; Glisson BS; Lee JS; Murphy WK; Umsawasdi T; Jeffries D
    Invest New Drugs; 1988 Sep; 6(3):217-8. PubMed ID: 2847992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of resistance to tiazofurin in hepatoma 3924A.
    Jayaram HN; Pillwein K; Lui MS; Faderan MA; Weber G
    Biochem Pharmacol; 1986 Feb; 35(4):587-93. PubMed ID: 2868729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic action of taxol and tiazofurin in human ovarian, pancreatic and lung carcinoma cells.
    Taniki T; Prajda N; Monden Y; Weber G
    Cancer Biochem Biophys; 1993 Sep; 13(4):295-302. PubMed ID: 8521379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the mechanism of action of 2-beta-D-ribofuranosylthiazole-4-carboxamide--V. Factors governing the response of murine tumors to tiazofurin.
    Ahluwalia GS; Jayaram HN; Plowman JP; Cooney DA; Johns DG
    Biochem Pharmacol; 1984 Apr; 33(8):1195-203. PubMed ID: 6143562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advanced Lewis lung carcinoma cured by tiazofurin as a system to study delayed hemopoietic effects of cancer.
    Balducci L; Hardy CL
    Cancer Invest; 1988; 6(6):681-6. PubMed ID: 3245935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assay.
    Micha JP; Kucera PR; Preve CU; Rettenmaier MA; Stratton JA; DiSaia PJ
    Gynecol Oncol; 1985 Jul; 21(3):351-5. PubMed ID: 4007612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of tiazofurin in recurrent squamous cell carcinoma of the head and neck.
    Dimery IW; Neidhart JA; McCarthy K; Krakoff IH; Hong WK
    Cancer Treat Rep; 1987 Apr; 71(4):425-6. PubMed ID: 3548960
    [No Abstract]   [Full Text] [Related]  

  • 11. The antitumor effect of Tiazofurin (TR) consists of anti-proliferative and anti-invasive elements.
    Tóvári J; Bocsi J; Ladányi A; Lapis K; Timár J
    Anticancer Res; 1996; 16(6A):3307-12. PubMed ID: 9042305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of tiazofurin in human colon carcinoma HT-29.
    Zhen W; Jayaram HN; Weber G
    Cancer Invest; 1992; 10(6):505-11. PubMed ID: 1358409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tiazofurin action in leukemia: evidence for down-regulation of oncogenes and synergism with retinoic acid.
    Weber G; Yamaji Y; Nagai M; Natsumeda Y; Jayaram HN; Zhen WN; Paulik E
    Adv Enzyme Regul; 1990; 30():35-45. PubMed ID: 2206022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tiazofurin: biological effects and clinical uses.
    Tricot G; Jayaram HN; Weber G; Hoffman R
    Int J Cell Cloning; 1990 May; 8(3):161-70. PubMed ID: 2189014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2-beta-D-Ribofuranosylthiazole-4-carboxamide, a novel potential antitumor agent for lung tumors and metastases.
    Robins RK; Srivastava PC; Narayanan VL; Plowman J; Paull KD
    J Med Chem; 1982 Feb; 25(2):107-8. PubMed ID: 7057413
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative in vitro studies of Tiazofurin and a selenazole analog.
    Streeter DG; Robins RK
    Biochem Biophys Res Commun; 1983 Sep; 115(2):544-50. PubMed ID: 6138036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiinvasive effects of Tiazofurin on liver-metastatic human colon carcinoma xenografts.
    Lapis KY; Bocsi J; Tóvári J; Bartha I; Timár J; Rásó E
    Anticancer Res; 1996; 16(6A):3323-31. PubMed ID: 9042307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hematological and biochemical action of tiazofurin (NSC 286193) in a case of refractory acute myeloid leukemia.
    Tricot GJ; Jayaram HN; Nichols CR; Pennington K; Lapis E; Weber G; Hoffman R
    Cancer Res; 1987 Sep; 47(18):4988-91. PubMed ID: 3476200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic synergism of tiazofurin and selected antitumor drugs against sensitive and resistant P388 leukemia in mice.
    Harrison SD; O'Dwyer PJ; Trader MW
    Cancer Res; 1986 Jul; 46(7):3396-400. PubMed ID: 3708573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I evaluation and pharmacokinetics of tiazofurin (2-beta-D-ribofuranosylthiazole-4-carboxamide, NSC 286193).
    Melink TJ; Von Hoff DD; Kuhn JG; Hersh MR; Sternson LA; Patton TF; Siegler R; Boldt DH; Clark GM
    Cancer Res; 1985 Jun; 45(6):2859-65. PubMed ID: 3986813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.